chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Balance disorder, Dizziness, Fatigue, Incoherent
Clinical narrative: dizziness; incoherent; loss of balance; All common side effects besides nausea and vomiting; fatigue; injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting), VACCINATION SITE PAIN (injection site tenderness) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site tenderness). On 14-Jan-2021, the patient experienced INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting) and FATIGUE (fatigue). At the time of the report, INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting), VACCINATION SITE PAIN (injection site tenderness) and FATIGUE (fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-008002 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: dizziness; incoherent; loss of balance; All common side effects besides nausea and vomiting; fatigue; injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting), VACCINATION SITE PAIN (injection site tenderness) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site tenderness). On 14-Jan-2021, the patient experienced INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting) and FATIGUE (fatigue). At the time of the report, INCOHERENT (incoherent), BALANCE DISORDER (loss of balance), ADVERSE EVENT (All common side effects besides nausea and vomiting), VACCINATION SITE PAIN (injection site tenderness) and FATIGUE (fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-008002 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Mouth breathing
Clinical narrative: Chest tight; Short of breath; Mouth breathing; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest tight), DYSPNOEA (Short of breath) and MOUTH BREATHING (Mouth breathing) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L2D8) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE for an unknown indication.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced CHEST DISCOMFORT (Chest tight), DYSPNOEA (Short of breath) and MOUTH BREATHING (Mouth breathing). At the time of the report, CHEST DISCOMFORT (Chest tight), DYSPNOEA (Short of breath) and MOUTH BREATHING (Mouth breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Additional concomitant medications reported were blood pressure, diabetes, prostate medicine.  No treatment information was provided.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Injection site started to feel itchy; Warm to touch; A spontaneous report was received from a consumer  concerning a 75-year-old , female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site itchy and injection site warm.   The patient's medical history, was not provided.Concomitant medications was not reported.  On 12 Jan 2021  prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown)  for prophylaxis of COVID-19 infection.   On 13 Jan 2021 the patient felt injection site itchy and injection site warm. Treatment for the events  was unknown.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events injection site itchy and injection site warm was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Erythema, Peripheral swelling, Pruritus, Somnolence
Clinical narrative: My arm is very swollen; My arm is red; My arm is itchy; Knocked out on Tuesday January 12, 2021, I slept the whole day; Not much appetite; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Knocked out on Tuesday January 12, 2021, I slept the whole day), DECREASED APPETITE (Not much appetite), PERIPHERAL SWELLING (My arm is very swollen), ERYTHEMA (My arm is red) and PRURITUS (My arm is itchy) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Heart disease, unspecified.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced DECREASED APPETITE (Not much appetite). On 12-Jan-2021, the patient experienced SOMNOLENCE (Knocked out on Tuesday January 12, 2021, I slept the whole day). On an unknown date, the patient experienced PERIPHERAL SWELLING (My arm is very swollen), ERYTHEMA (My arm is red) and PRURITUS (My arm is itchy). At the time of the report, SOMNOLENCE (Knocked out on Tuesday January 12, 2021, I slept the whole day), DECREASED APPETITE (Not much appetite), PERIPHERAL SWELLING (My arm is very swollen), ERYTHEMA (My arm is red) and PRURITUS (My arm is itchy) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the events included paracetamol.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm  sensation at the injection site; Injection site itchiness; Injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm  sensation at the injection site), VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm  sensation at the injection site), VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Injection site redness). At the time of the report, VACCINATION SITE WARMTH (Warm  sensation at the injection site), VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment was received.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Headache, Injection site pain
Clinical narrative: Backache; Headache; Pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), HEADACHE (Headache) and INJECTION SITE PAIN (Pain in the injection site) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in April 2020.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced BACK PAIN (Backache), HEADACHE (Headache) and INJECTION SITE PAIN (Pain in the injection site). At the time of the report, BACK PAIN (Backache), HEADACHE (Headache) and INJECTION SITE PAIN (Pain in the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Lacrimation increased, Rhinorrhoea
Clinical narrative: Loose bowel; Runny eyes; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose bowel), LACRIMATION INCREASED (Runny eyes) and RHINORRHOEA (Runny nose) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history not reported.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DIARRHOEA (Loose bowel), LACRIMATION INCREASED (Runny eyes) and RHINORRHOEA (Runny nose). At the time of the report, DIARRHOEA (Loose bowel), LACRIMATION INCREASED (Runny eyes) and RHINORRHOEA (Runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.  Company Comment: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Urticaria, Vaccination site erythema, Vaccination site pain
Clinical narrative: shingles; itchy hives on the stomach; soreness at the injection site; redness at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), URTICARIA (itchy hives on the stomach) and HERPES ZOSTER (shingles) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). On 15-Jan-2021, the patient experienced URTICARIA (itchy hives on the stomach).   On 22-Jan-2021, the patient experienced HERPES ZOSTER (shingles). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), URTICARIA (itchy hives on the stomach) and HERPES ZOSTER (shingles) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications include antiviral medication. Concomitant product use was not provided by the reporter.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site rash
Clinical narrative: rash appearing on my arm yesterday where I got the vaccine; soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash appearing on my arm yesterday where I got the vaccine) and INJECTION SITE PAIN (soreness) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Injection site rash on 17-Feb-2021 and Pain injection site on 11-Feb-2021.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE PAIN (soreness). On 17-Feb-2021, the patient experienced INJECTION SITE RASH (rash appearing on my arm yesterday where I got the vaccine). On 12-Feb-2021, INJECTION SITE PAIN (soreness) outcome was unknown. At the time of the report, INJECTION SITE RASH (rash appearing on my arm yesterday where I got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant product use were not provided by the reporter.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pruritus
Clinical narrative: itchiness and redness at the injection site; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness and redness at the injection site) and FATIGUE (fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced FATIGUE (fatigue). On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness and redness at the injection site). On 14-Jan-2021, FATIGUE (fatigue) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itchiness and redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment include cortisone cream.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle fatigue, Pain in extremity, Paraesthesia
Clinical narrative: Arm was sore and painful; Index finger/fingers tingly; Elbow area is fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore and painful), PARAESTHESIA (Index finger/fingers tingly) and MUSCLE FATIGUE (Elbow area is fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PAIN IN EXTREMITY (Arm was sore and painful), PARAESTHESIA (Index finger/fingers tingly) and MUSCLE FATIGUE (Elbow area is fatigue). At the time of the report, PAIN IN EXTREMITY (Arm was sore and painful), PARAESTHESIA (Index finger/fingers tingly) and MUSCLE FATIGUE (Elbow area is fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site rash, Vaccination site urticaria
Clinical narrative: itching; I broke out in welts around the injection site; I broke out in a rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), VACCINATION SITE URTICARIA (I broke out in welts around the injection site) and VACCINATION SITE RASH (I broke out in a rash around the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure raised, Diabetes and Restless legs.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PRURITUS (itching), VACCINATION SITE URTICARIA (I broke out in welts around the injection site) and VACCINATION SITE RASH (I broke out in a rash around the injection site). At the time of the report, PRURITUS (itching), VACCINATION SITE URTICARIA (I broke out in welts around the injection site) and VACCINATION SITE RASH (I broke out in a rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified medication for blood pressure, diabetes and restless legs were noted. Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received included no new information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site swelling, Injection site warmth
Clinical narrative: Warm touch at the injection site; rump at injection site; Red rump at the injection site; Swollen rump at site of injection; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE WARMTH (Warm touch at the injection site), INJECTION SITE MASS (rump at injection site), INJECTION SITE ERYTHEMA (Red rump at the injection site) and INJECTION SITE SWELLING (Swollen rump at site of injection) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced INJECTION SITE WARMTH (Warm touch at the injection site), INJECTION SITE MASS (rump at injection site), INJECTION SITE ERYTHEMA (Red rump at the injection site) and INJECTION SITE SWELLING (Swollen rump at site of injection). At the time of the report, INJECTION SITE WARMTH (Warm touch at the injection site), INJECTION SITE MASS (rump at injection site), INJECTION SITE ERYTHEMA (Red rump at the injection site) and INJECTION SITE SWELLING (Swollen rump at site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. The patient was treated with Benadryl and applied Hydrocortisone.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 107) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 107) and CHILLS (chills). At the time of the report, PYREXIA (fever of 107) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature (107-Unknown):.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: neck pain; shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of   in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Arm fracture.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Exposure during pregnancy, Ultrasound abdomen normal
Clinical narrative: 4 and a half months pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (4 and a half months pregnant) in a 34-year-old female patient  who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history.). Concomitant products included ALCOHOL and PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. The patient's last menstrual period was on 19-Sep-2020 and the estimated date of delivery was 29-Jun-2021. On 23-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (4 and a half months pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  eighteenth week of the pregnancy.  On 23-Jan-2021, EXPOSURE DURING PREGNANCY (4 and a half months pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test normal: normal (normal) normal. On an unknown date, Ultrasound abdomen normal: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This is a case of product exposure during pregnancy with no associated AEs for this 34-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 34-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Stomach ache; Leg pain; Pain in extremity; Fatigue; Nausea; Headache; Feeling bad / aching; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Leg pain), PAIN IN EXTREMITY (Pain in extremity), FATIGUE (Fatigue) and NAUSEA (Nausea) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03AX20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Allergy (allergies to Sulfur and Kflex) and Hypertension.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Leg pain), PAIN IN EXTREMITY (Pain in extremity), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and MYALGIA (Feeling bad / aching). At the time of the report, ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Leg pain), PAIN IN EXTREMITY (Pain in extremity), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and MYALGIA (Feeling bad / aching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Stomach ache; Leg pain; Pain in extremity; Fatigue; Nausea; Headache; Feeling bad / aching; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Leg pain), PAIN IN EXTREMITY (Pain in extremity), FATIGUE (Fatigue) and NAUSEA (Nausea) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03AX20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Allergy (allergies to Sulfur and Kflex) and Hypertension.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Leg pain), PAIN IN EXTREMITY (Pain in extremity), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and MYALGIA (Feeling bad / aching). At the time of the report, ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Leg pain), PAIN IN EXTREMITY (Pain in extremity), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and MYALGIA (Feeling bad / aching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Eye pain, Feeling cold, Headache, Insomnia
Clinical narrative: Eyes are closed with pain; Unable to sleep; Body aches; Shaking chills; Fever; Headache; Cold; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Cold), EYE PAIN (Eyes are closed with pain), INSOMNIA (Unable to sleep), MYALGIA (Body aches) and CHILLS (Shaking chills) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced FEELING COLD (Cold), INSOMNIA (Unable to sleep), MYALGIA (Body aches), CHILLS (Shaking chills), PYREXIA (Fever) and HEADACHE (Headache). On 15-Jan-2021, the patient experienced EYE PAIN (Eyes are closed with pain). At the time of the report, FEELING COLD (Cold), EYE PAIN (Eyes are closed with pain), INSOMNIA (Unable to sleep), MYALGIA (Body aches), CHILLS (Shaking chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Reporter's Comments: Based on the current available information and temporal association between the product and the start date of the events a causal relational cannot be excluded.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Eyes are closed with pain; Unable to sleep; Body aches; Shaking chills; Fever; Headache; Cold; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Cold), EYE PAIN (Eyes are closed with pain), INSOMNIA (Unable to sleep), MYALGIA (Body aches) and CHILLS (Shaking chills) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced FEELING COLD (Cold), INSOMNIA (Unable to sleep), MYALGIA (Body aches), CHILLS (Shaking chills), PYREXIA (Fever) and HEADACHE (Headache). On 15-Jan-2021, the patient experienced EYE PAIN (Eyes are closed with pain). At the time of the report, FEELING COLD (Cold), EYE PAIN (Eyes are closed with pain), INSOMNIA (Unable to sleep), MYALGIA (Body aches), CHILLS (Shaking chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Reporter's Comments: Based on the current available information and temporal association between the product and the start date of the events a causal relational cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash, vert heavy rash; Itching and very itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash, vert heavy rash) and PRURITUS (Itching and very itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Thyroid disorder NOS and Drug allergy (Patient cannot take Benadryl.). Concomitant products included MONTELUKAST for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid therapy, FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced RASH (Rash, vert heavy rash) and PRURITUS (Itching and very itchy). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) at an unspecified dose and frequency. On 15-Jan-2021, RASH (Rash, vert heavy rash) and PRURITUS (Itching and very itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Chills, Fatigue, Headache
Clinical narrative: Shivery; Felt tired; Fever; Chills; Low grade headache; Arm soreness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Arm soreness), CHILLS (Chills), HEADACHE (Low grade headache), FATIGUE (Felt tired) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness). On 06-Jan-2021, the patient experienced CHILLS (Chills) and HEADACHE (Low grade headache). On 11-Jan-2021, the patient experienced FATIGUE (Felt tired) and PYREXIA (Fever). On 12-Jan-2021, the patient experienced CHILLS (Shivery). On 08-Jan-2021, VACCINATION SITE PAIN (Arm soreness) had resolved. At the time of the report, CHILLS (Chills) and HEADACHE (Low grade headache) had not resolved and FATIGUE (Felt tired), PYREXIA (Fever) and CHILLS (Shivery) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Body temperature: 98.8. On 12-Jan-2021, Body temperature:. On 12-Jan-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Shivery; Felt tired; Fever; Chills; Low grade headache; Arm soreness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Arm soreness), CHILLS (Chills), HEADACHE (Low grade headache), FATIGUE (Felt tired) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness). On 06-Jan-2021, the patient experienced CHILLS (Chills) and HEADACHE (Low grade headache). On 11-Jan-2021, the patient experienced FATIGUE (Felt tired) and PYREXIA (Fever). On 12-Jan-2021, the patient experienced CHILLS (Shivery). On 08-Jan-2021, VACCINATION SITE PAIN (Arm soreness) had resolved. At the time of the report, CHILLS (Chills) and HEADACHE (Low grade headache) had not resolved and FATIGUE (Felt tired), PYREXIA (Fever) and CHILLS (Shivery) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Body temperature: 98.8. On 12-Jan-2021, Body temperature:. On 12-Jan-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching; Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching; Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching), PRURITUS (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching) and RASH (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced ERYTHEMA (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching), PRURITUS (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching) and RASH (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching). At the time of the report, ERYTHEMA (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching), PRURITUS (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching) and RASH (Extensive body rash on chest, stomach, back, forearms, bicep, thighs pretty red with a lot of itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.; Sender's Comments: Based on the current available information which shows a temporal association between the use of the mRNA-1273 and the reported events, a causal relationship with the events cannot be excluded. Rash is consistent with the product safety profile.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Paranasal sinus discomfort, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PARANASAL SINUS DISCOMFORT (sinus pressure behined her eyes), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19 since 08-Jan-2021.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PARANASAL SINUS DISCOMFORT (sinus pressure behined her eyes), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell). At the time of the report, PARANASAL SINUS DISCOMFORT (sinus pressure behined her eyes), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Injection site redness; INjection site itchiness; Injection site warmth; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE PRURITUS (INjection site itchiness) and INJECTION SITE WARMTH (Injection site warmth) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 15-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE PRURITUS (INjection site itchiness) and INJECTION SITE WARMTH (Injection site warmth). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE PRURITUS (INjection site itchiness) and INJECTION SITE WARMTH (Injection site warmth) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever 100.7F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100.7F) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PYREXIA (Fever 100.7F). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 15-Jan-2021, PYREXIA (Fever 100.7F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Body temperature: 100.7f (High) 100.7F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye irritation, Eye pruritus, Eyelid ptosis, Headache
Clinical narrative: Burning Sensation in the Right Eye; Itchy around Right Eye; Swollen Face; Red Face; Drooping Right Eye; Headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Burning Sensation in the Right Eye), EYE PRURITUS (Itchy around Right Eye), SWELLING FACE (Swollen Face), ERYTHEMA (Red Face) and EYELID PTOSIS (Drooping Right Eye) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced EYE IRRITATION (Burning Sensation in the Right Eye), EYE PRURITUS (Itchy around Right Eye), SWELLING FACE (Swollen Face), ERYTHEMA (Red Face), EYELID PTOSIS (Drooping Right Eye) and HEADACHE (Headache). At the time of the report, EYE IRRITATION (Burning Sensation in the Right Eye), EYE PRURITUS (Itchy around Right Eye), SWELLING FACE (Swollen Face), ERYTHEMA (Red Face), EYELID PTOSIS (Drooping Right Eye) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Burning Sensation in the Right Eye; Itchy around Right Eye; Swollen Face; Red Face; Drooping Right Eye; Headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Burning Sensation in the Right Eye), EYE PRURITUS (Itchy around Right Eye), SWELLING FACE (Swollen Face), ERYTHEMA (Red Face) and EYELID PTOSIS (Drooping Right Eye) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced EYE IRRITATION (Burning Sensation in the Right Eye), EYE PRURITUS (Itchy around Right Eye), SWELLING FACE (Swollen Face), ERYTHEMA (Red Face), EYELID PTOSIS (Drooping Right Eye) and HEADACHE (Headache). At the time of the report, EYE IRRITATION (Burning Sensation in the Right Eye), EYE PRURITUS (Itchy around Right Eye), SWELLING FACE (Swollen Face), ERYTHEMA (Red Face), EYELID PTOSIS (Drooping Right Eye) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Erythema, Myalgia, Peripheral swelling
Clinical narrative: fever; chills; muscle aches; left arm red; left arm swollen; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (fever), CHILLS (chills), MYALGIA (muscle aches), ERYTHEMA (left arm red) and PERIPHERAL SWELLING (left arm swollen) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037KZOA) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historic conditions for the patient.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (muscle aches), ERYTHEMA (left arm red) and PERIPHERAL SWELLING (left arm swollen). At the time of the report, PYREXIA (fever), CHILLS (chills), MYALGIA (muscle aches), ERYTHEMA (left arm red) and PERIPHERAL SWELLING (left arm swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.